ESSA Pharma Inc.
EPIX · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$29 | -$27 | -$35 | -$37 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | -$0 |
| Stock-Based Comp. | $7 | $5 | $0 | $0 |
| Change in WC | -$0 | $2 | -$1 | $2 |
| Other Non-Cash | -$0 | -$1 | -$1 | -$0 |
| Operating Cash Flow | -$23 | -$20 | -$29 | -$25 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$39 | -$365 | -$296 | -$57 |
| Inv. Sales/Matur. | $131 | $362 | $243 | $22 |
| Other Inv. Act. | $0 | $0 | $1 | -$0 |
| Investing Cash Flow | $92 | -$4 | -$52 | -$35 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$0 | -$0 | -$0 |
| Stock Issued | $1 | $0 | $0 | $150 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$8 |
| Financing Cash Flow | $1 | -$0 | $0 | $142 |
| Forex Effect | $0 | $0 | $0 | -$0 |
| Net Chg. in Cash | $70 | -$23 | -$81 | $82 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $34 | $57 | $138 | $56 |
| End Cash | $104 | $34 | $57 | $138 |
| Free Cash Flow | -$23 | -$20 | -$29 | -$25 |